ReviewACS omega2026
Adaptive Polymers: The pH-Responsive Revolution in Biomedical Materials.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
pH-responsive polymers represent a transformative class of smart materials that adapt their physicochemical properties in response to environmental pH changes. This dynamic behavior enables precise control over drug release, tissue interaction, and diagnostic performance, making them highly relevant for advanced healthcare applications. These polymers exploit ionizable functional groups that undergo protonation or deprotonation, triggering conformational changes, solubility shifts, or swelling behavior. Such responsiveness is particularly advantageous in physiological contexts where pH gradients exist, such as the gastrointestinal tract, tumor microenvironments, and intracellular compartments. Recent advances have expanded their utility from simple drug carriers to multifunctional platforms integrating targeting, imaging, and therapeutic functions. Innovations in polymer design, such as block copolymers, hydrogels, and nanostructured assemblies, have improved biocompatibility, tunability, and responsiveness, enabling controlled delivery of small molecules, proteins, and nucleic acids. Furthermore, hybrid systems combining pH-sensitive polymers with inorganic or biological components have opened new avenues for personalized medicine and regenerative therapies. Despite significant progress, challenges remain in achieving predictable
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.